Navigation Links
CTRC-AACR San Antonio Breast Cancer Symposium continues to expand
Date:12/3/2009

PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal of eradicating breast cancer.

This year, more than 8,500 scientists and other professionals will gather at the Henry B. Gonzales Convention Center in San Antonio from Dec. 9-13, 2009. The symposium is a partnership between the American Association for Cancer Research, the University of Texas Health Science Center and Baylor College of Medicine.

Last year, more than 8,000 people attended from 92 countries; 46 percent of the participants were medical doctors and 9 percent were basic research scientists. Last year was the first year the AACR partnered with the symposium in an effort to help increase the presence of basic science. As a result, the meeting began one day earlier than in past years and held standing room only scientific sessions.

"The San Antonio Breast Cancer Symposium is arguably the best cancer research meeting in the world, and with the addition of high quality science, credibility and outreach efforts from the American Association for Cancer Research, this collaboration continues to garner further scientific prominence," said C. Kent Osborne, M.D., director of the Dan L. Duncan Center and the Lester and Sue Smith Breast Center at Baylor College of Medicine and president of the symposium.

This year, in addition to the main program, the CTRC-AACR-SABCS press office will host four press conferences for the media highlighting important news from the meeting and a separate media Q&A on December 12 at 10:00 a.m. CT with Dennis Slamon, M.D., Ph.D. on the long-term survival, disease free survival and cardiac toxicity results from his latest research with Herceptin.

The following is a schedule of the press briefings.

  • Bisphosphonates: 12:30 p.m. CT, Thursday, Dec. 10
  • Drugs in the Pipeline: 8:00 a.m. CT, Friday, Dec. 11
  • New Treatment Paradigms: 12:30 p.m. CT, Friday, Dec. 11
  • Patient Management and Prognosis: 8:00 a.m. CT, Saturday, Dec. 12
  • Media Q&A with Dennis Slamon, M.D., Ph.D, 10:00 a.m. CT, Saturday, Dec. 12

Beyond the press conferences, the press office has selected additional abstracts that may be of interest to the media and will be highlighting them as separate press releases.

AACR will be conducting interviews with researchers throughout the symposium. Recordings of these events and interviews will be posted to AACR Scientific Podcast feed. You can subscribe to this feed through following links:

AACR Scientific Podcast RSS Reader: http://feeds.feedburner.com/AacrScientificPodcasts

AACR RSS News Feed: http://feeds.feedburner.com/aacr


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. CTRC-AACR San Antonio Breast Cancer Symposium
2. 31st Annual San Antonio Breast Cancer Symposium
3. Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25
4. UTSA wins San Antonio Area Foundation grant to further chlamydia research
5. UT San Antonio researcher wins $917,000 from NIH to study memory
6. Newly created cancer stem cells could aid breast cancer research
7. Linchpin gene may be useful target for new breast cancer therapies
8. Dietary calcium could possibly prevent the spread of breast cancer to bone
9. Researchers find new gene linked to breast cancer
10. Analysis of breast and colon cancer genes finds many areas of differences between tumors
11. Genome update defines landscape of breast and colon cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. ... has been advised by its major shareholders, Clean Technology ... United States based venture capital ... shares of Biorem (on a fully diluted, as converted ... the disposition of their entire equity holdings in Biorem ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: